Carmen Ghilardi

975 total citations
23 papers, 635 citations indexed

About

Carmen Ghilardi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Carmen Ghilardi has authored 23 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Carmen Ghilardi's work include Ovarian cancer diagnosis and treatment (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Carmen Ghilardi is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Carmen Ghilardi collaborates with scholars based in Italy, United States and Singapore. Carmen Ghilardi's co-authors include Raffaella Giavazzi, Maria Rosa Bani, Giovanna Chiorino, Alessandra Decio, Patrizia Borsotti, Robert Fruscio, Giulia Taraboletti, Maria Nicoletti, Antonietta Rosa Silini and Romina Dossi and has published in prestigious journals such as Cancer Research, Oncogene and Endocrinology.

In The Last Decade

Carmen Ghilardi

22 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Ghilardi Italy 14 384 243 178 96 61 23 635
Tsutomu Imai Japan 8 595 1.5× 330 1.4× 316 1.8× 117 1.2× 75 1.2× 15 900
Antonella Perotti Italy 12 230 0.6× 316 1.3× 97 0.5× 67 0.7× 55 0.9× 25 591
Magali Castells France 9 279 0.7× 254 1.0× 203 1.1× 74 0.8× 223 3.7× 9 723
Romina Dossi Italy 10 453 1.2× 201 0.8× 158 0.9× 27 0.3× 70 1.1× 11 708
W. Ruprecht Wiedemeyer United States 9 376 1.0× 369 1.5× 223 1.3× 76 0.8× 41 0.7× 12 718
Marisa Mariani United States 15 476 1.2× 249 1.0× 235 1.3× 42 0.4× 61 1.0× 24 758
Clara Salamanca Canada 12 382 1.0× 178 0.7× 170 1.0× 290 3.0× 72 1.2× 15 708
Mélanie Mestdagt Belgium 11 568 1.5× 382 1.6× 211 1.2× 118 1.2× 159 2.6× 13 1.0k
Salvatore A. Del Prete United States 10 307 0.8× 374 1.5× 154 0.9× 32 0.3× 99 1.6× 13 665
Hans Petter Eikesdal Norway 19 496 1.3× 412 1.7× 292 1.6× 27 0.3× 98 1.6× 41 987

Countries citing papers authored by Carmen Ghilardi

Since Specialization
Citations

This map shows the geographic impact of Carmen Ghilardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Ghilardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Ghilardi more than expected).

Fields of papers citing papers by Carmen Ghilardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Ghilardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Ghilardi. The network helps show where Carmen Ghilardi may publish in the future.

Co-authorship network of co-authors of Carmen Ghilardi

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Ghilardi. A scholar is included among the top collaborators of Carmen Ghilardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Ghilardi. Carmen Ghilardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anastasia, Alessia, Paola Ostano, Lucia Minoli, et al.. (2025). Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient‐derived xenograft models. Molecular Oncology. 19(4). 1075–1091.
2.
Decio, Alessandra, Mark R. Albertella, Joanne Wilson, et al.. (2023). The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin. Cancer Research Communications. 3(3). 489–500. 9 indexed citations
3.
Panini, Nicolò, Paola Fabbrizio, Cristina Matteo, et al.. (2023). Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells. OncoImmunology. 12(1). 2239035–2239035. 5 indexed citations
4.
Arrigoni, Chiara, Paola Ostano, Simone Bersini, et al.. (2023). Differential angiogenesis of bone and muscle endothelium in aging and inflammatory processes. Communications Biology. 6(1). 126–126. 9 indexed citations
5.
6.
Anastasia, Alessia, Antonio Ramos‐Montoya, Giovanna Chiorino, et al.. (2022). The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases. Molecular Cancer Therapeutics. 21(4). 555–567. 25 indexed citations
7.
Bani, Maria Rosa, Alessandra Decio, Raffaella Giavazzi, & Carmen Ghilardi. (2017). Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists. Angiogenesis. 20(2). 233–241. 23 indexed citations
8.
Ghilardi, Carmen, et al.. (2016). PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration. Thrombosis Research. 140. S192–S193. 6 indexed citations
9.
Ricci, Francesca, Francesca Bizzaro, Marta Cesca, et al.. (2014). Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations. Cancer Research. 74(23). 6980–6990. 104 indexed citations
10.
Pretto, Francesca, Carmen Ghilardi, Michele Moschetta, et al.. (2014). Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle. Oncotarget. 6(5). 3043–3054. 39 indexed citations
11.
Borsotti, Patrizia, Carmen Ghilardi, Paola Ostano, et al.. (2014). Thrombospondin‐1 is part of a Slug‐independent motility and metastatic program in cutaneous melanoma, in association with VEGFR‐1 and FGF‐2. Pigment Cell & Melanoma Research. 28(1). 73–81. 42 indexed citations
12.
Belotti, Dorina, Brian J. North, Carmen Ghilardi, et al.. (2012). Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies. Neoplasia. 14(9). 846–IN16. 27 indexed citations
13.
Silini, Antonietta Rosa, Carmen Ghilardi, Fabio Sangalli, et al.. (2011). Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor’s proangiogenic microenvironment. Cellular and Molecular Life Sciences. 69(7). 1167–1178. 43 indexed citations
14.
Moretti, Roberta M., Stefania Mai, Marina Montagnani Marelli, et al.. (2010). Dual Targeting of Tumor and Endothelial Cells by Gonadotropin-Releasing Hormone Agonists to Reduce Melanoma Angiogenesis. Endocrinology. 151(10). 4643–4653. 13 indexed citations
15.
Silini, Antonietta Rosa, Carmen Ghilardi, Sergio Bernasconi, et al.. (2009). Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype. Clinical & Experimental Metastasis. 27(1). 43–53. 15 indexed citations
16.
Ghilardi, Carmen, Giovanna Chiorino, Romina Dossi, et al.. (2008). Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium. BMC Genomics. 9(1). 201–201. 48 indexed citations
17.
Garofalo, Angela, Luigi Manenti, Carmen Ghilardi, et al.. (2003). The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.. PubMed. 9(9). 3476–85. 52 indexed citations
18.
Procacci, Carlo, et al.. (2002). [Serous cystadenoma of the pancreas: imaging findings].. PubMed. 102(1-2). 23–31. 10 indexed citations
19.
Vikhanskaya, Faina, Maria Rosa Bani, Patrizia Borsotti, et al.. (2001). p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Oncogene. 20(50). 7293–7300. 48 indexed citations
20.
Taraboletti, Giulia, Veronica Vergani, Roberta Ceruti, et al.. (2000). Posttranscriptional Stimulation of Endothelial Cell Matrix Metalloproteinases 2 and 1 by Endothelioma Cells. Experimental Cell Research. 258(2). 384–394. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsutomu Imai Breakdown of academic impact, for papers by Antonella Perotti Breakdown of academic impact, for papers by Magali Castells Breakdown of academic impact, for papers by Romina Dossi Breakdown of academic impact, for papers by W. Ruprecht Wiedemeyer Breakdown of academic impact, for papers by Marisa Mariani Breakdown of academic impact, for papers by Clara Salamanca Breakdown of academic impact, for papers by Mélanie Mestdagt Breakdown of academic impact, for papers by Salvatore A. Del Prete Breakdown of academic impact, for papers by Hans Petter Eikesdal
Rankless by CCL
2026